Angiotensin-Converting Enzyme Inhibitor-based Versus Angiotensin Receptor Blocker-based Optimal Medical Therapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study.
J Cardiovasc Pharmacol
; 77(1): 61-68, 2021 01 01.
Article
in En
| MEDLINE
| ID: mdl-33165139
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Coronary Artery Disease
/
Angiotensin-Converting Enzyme Inhibitors
/
Angiotensin Receptor Antagonists
/
Percutaneous Coronary Intervention
/
Angina Pectoris
/
Myocardial Infarction
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
J Cardiovasc Pharmacol
Year:
2021
Type:
Article